Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-089008)

Filing Details

Accession Number:: 0001144204-16-089008
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-18 21:33:54
Reporting Period:: 2016-03-16

Filing Date:: 2016-03-18
Accepted Time:: 2016-03-18 21:33:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133869	Capricor Therapeutics Inc.	CAPR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1269910	Center Medical Sinai Cedars	8700 Beverly Blvd Los Angeles CA 90048-1865		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-16	416,666	$2.40	2,592,298	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to Buy)	Acquisiton	2016-03-16	208,333	$0.00	208,333	$4.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
208,333	2016-09-17	2019-03-16	No	4	P	Direct

Footnotes

The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on March 16, 2016, purchased (i) 416,666 shares of the Issuer's common stock at a purchase price of $2.40 per share, and (ii) warrants to purchase up to an aggregate of 208,333 shares of the Issuer's common stock, for an aggregate purchase price of approximately $1,000,000.